Stay updated on Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Adds a dedicated Locations section highlighting Maryland as a study site. The page revision updates to v3.3.3 and the HHS Vulnerability Disclosure link is removed.
    Difference
    0.2%
    Check dated 2025-12-23T22:29:11.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a new 'Last Update Posted (Estimated)' label in the Study Record Dates section, replacing the previous 'Last Update Posted' entry.
    Difference
    0.2%
    Check dated 2025-12-09T19:38:25.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    New and removed update date entries (e.g., 2025-12-02, 2025-11-29, 2025-11-28; and 2025-11-20, 2025-11-19, 2025-04-22) appear as update timestamps on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-12-02T17:11:00.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Updates to the page history show a new revision (v3.3.2) with dates 2025-11-19 and 2025-11-20, and removals of earlier entries including 2025-08-26/27 and v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-25T11:49:43.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Removed the notice about a lapse in government funding from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:14:53.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The updates shown appear limited to metadata and page formatting, with no changes to core study details such as eligibility criteria or outcome measures; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:24:48.000Z thumbnail image

Stay in the know with updates to Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.